￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Information about tucatinib/tucatinib generics

2026-02-01 22:25:32

Check Details
How long does it take to take Alpelisib to develop drug resistance?

2026-02-01 22:25:32

Check Details
Inluriyo (Imlunestrant) Dosage and Usage

2026-02-01 22:25:32

Check Details
What are the specific side effects and contraindications of Besudil/Yilaike?

2026-02-01 22:25:32

Check Details
Standard Usage and Dosage Guidelines for Brivaracetam Tablets

2026-02-01 22:25:32

Check Details
What does the instructions for Obeticholic acid contain?

2026-02-01 22:25:32

Check Details
Who is the manufacturer of neratinib/neratinib?

2026-02-01 22:25:32

Check Details
Why is it not recommended to use bedaquiline/snareli for a long time? Are there any risks?

2026-02-01 22:25:32

Check Details
FDA approves immunosuppressant Inluriyo (Imlunestrant) for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

2026-02-01 22:25:32

Check Details
FDA Issues CRL for Dasatinib/Startase in Patients with Chronic Myelogenous Leukemia

2026-02-01 22:25:32

Check Details
Description of what type of drug is baricitinib/alemin?

2026-02-01 22:25:32

Check Details
Real-world efficacy and safety of trastuzumab vs. trastuzumab and tucatinib as second- and third-line treatments for HER2-positive metastatic breast cancer

2026-02-01 22:25:32

Check Details
Category
相关知识